Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

GBD 2016 Headache Collaborators, Lars Jacob Stovner, Emma Nichols, Timothy J Steiner, Foad Abd-Allah, Ahmed Abdelalim, Rajaa M Al-Raddadi, Mustafa Geleto Ansha, Aleksandra Barac, Isabela M Bensenor, Linh Phuong Doan, Dumessa Edessa, Matthias Endres, Kyle J Foreman, Fortune Gbetoho Gankpe, Gururaj Gopalkrishna, Alessandra C Goulart, Rahul Gupta, Graeme J Hankey, Simon I Hay, Mohamed I Hegazy, Esayas Haregot Hilawe, Amir Kasaeian, Dessalegn H Kassa, Ibrahim Khalil, Young-Ho Khang, Jagdish Khubchandan, Yun Jin Kim, Yoshihiro Kokubo, Mohammed A Mohammed, Ali H Mokdad, Maziar Moradi-Lakeh, Huong Lan Thi Nguyen, Yirga Legesse Nirayo, Mostafa Qorbani, Anna Ranta, Kedir T Roba, Saeid Safiri, Itamar S Santos, Maheswar Satpathy, Monika Sawhney, Mekonnen Sisay Shiferaw, Ivy Shiue, Mari Smith, Cassandra E I Szoeke, Nu Thi Truong, Narayanaswamy Venketasubramanian, Kidu Gidey Weldegwergs, Ronny Westerman, Tissa Wijeratne, Bach Xuan Tran, Naohiro Yonemoto, Valery L Feigin, Theo Vos, Christopher J L Murray, GBD 2016 Headache Collaborators, Lars Jacob Stovner, Emma Nichols, Timothy J Steiner, Foad Abd-Allah, Ahmed Abdelalim, Rajaa M Al-Raddadi, Mustafa Geleto Ansha, Aleksandra Barac, Isabela M Bensenor, Linh Phuong Doan, Dumessa Edessa, Matthias Endres, Kyle J Foreman, Fortune Gbetoho Gankpe, Gururaj Gopalkrishna, Alessandra C Goulart, Rahul Gupta, Graeme J Hankey, Simon I Hay, Mohamed I Hegazy, Esayas Haregot Hilawe, Amir Kasaeian, Dessalegn H Kassa, Ibrahim Khalil, Young-Ho Khang, Jagdish Khubchandan, Yun Jin Kim, Yoshihiro Kokubo, Mohammed A Mohammed, Ali H Mokdad, Maziar Moradi-Lakeh, Huong Lan Thi Nguyen, Yirga Legesse Nirayo, Mostafa Qorbani, Anna Ranta, Kedir T Roba, Saeid Safiri, Itamar S Santos, Maheswar Satpathy, Monika Sawhney, Mekonnen Sisay Shiferaw, Ivy Shiue, Mari Smith, Cassandra E I Szoeke, Nu Thi Truong, Narayanaswamy Venketasubramanian, Kidu Gidey Weldegwergs, Ronny Westerman, Tissa Wijeratne, Bach Xuan Tran, Naohiro Yonemoto, Valery L Feigin, Theo Vos, Christopher J L Murray

Abstract

Background: Through the Global Burden of Diseases, Injuries, and Risk Factors (GBD) studies, headache has emerged as a major global public health concern. We aimed to use data from the GBD 2016 study to provide new estimates for prevalence and years of life lived with disability (YLDs) for migraine and tension-type headache and to present the methods and results in an accessible way for clinicians and researchers of headache disorders.

Methods: Data were derived from population-based cross-sectional surveys on migraine and tension-type headache. Prevalence for each sex and 5-year age group interval (ie, age 5 years to ≥95 years) at different time points from 1990 and 2016 in all countries and GBD regions were estimated using a Bayesian meta-regression model. Disease burden measured in YLDs was calculated from prevalence and average time spent with headache multiplied by disability weights (a measure of the relative severity of the disabling consequence of a disease). The burden stemming from medication overuse headache, which was included in earlier iterations of GBD as a separate cause, was subsumed as a sequela of either migraine or tension-type headache. Because no deaths were assigned to headaches as the underlying cause, YLDs equate to disability-adjusted life-years (DALYs). We also analysed results on the basis of the Socio-demographic Index (SDI), a compound measure of income per capita, education, and fertility.

Findings: Almost three billion individuals were estimated to have a migraine or tension-type headache in 2016: 1·89 billion (95% uncertainty interval [UI] 1·71-2·10) with tension-type headache and 1·04 billion (95% UI 1·00-1·09) with migraine. However, because migraine had a much higher disability weight than tension-type headache, migraine caused 45·1 million (95% UI 29·0-62·8) and tension-type headache only 7·2 million (95% UI 4·6-10·5) YLDs globally in 2016. The headaches were most burdensome in women between ages 15 and 49 years, with migraine causing 20·3 million (95% UI 12·9-28·5) and tension-type headache 2·9 million (95% UI 1·8-4·2) YLDs in 2016, which was 11·2% of all YLDs in this age group and sex. Age-standardised DALYs for each headache type showed a small increase as SDI increased.

Interpretation: Although current estimates are based on limited data, our study shows that headache disorders, and migraine in particular, are important causes of disability worldwide, and deserve greater attention in health policy debates and research resource allocation. Future iterations of this study, based on sources from additional countries and with less methodological heterogeneity, should help to provide stronger evidence of the need for action.

Funding: Bill & Melinda Gates Foundation.

Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
Age-standardised prevalence of migraine per 100 000 population by location for both sexes, 2016 ATG=Antigua and Barbuda. FSM=Federated States of Micronesia. LCA=Saint Lucia. TLS=Timor-Leste. TTO=Trinidad and Tobago. VCT=Saint Vincent and the Grenadines.
Figure 2
Figure 2
Age-standardised prevalence of tension-type headache per 100 000 population by location for both sexes, 2016 ATG=Antigua and Barbuda. FSM=Federated States of Micronesia. LCA=Saint Lucia. TLS=Timor-Leste. TTO=Trinidad and Tobago. VCT=Saint Vincent and the Grenadines.
Figure 3
Figure 3
Global prevalence of (A) migraine and (B) tension-type headache by age and sex, 2016 Prevalence is expressed as the percentage of the population that is affected by the disease. Shaded areas show 95% uncertainty intervals. Values are plotted at the midpoint of 5-year age categories.
Figure 4
Figure 4
Global years of life lived with disability (YLD) rate per 100 000 population due to migraine and tension-type headache by age, 2016 Shaded areas show 95% uncertainty intervals. Values are plotted at the midpoint of 5-year age categories.
Figure 5
Figure 5
Age-standardised disability-adjusted-life-years (DALY) rates for (A) migraine and (B) tension-type headache by 21 Global Burden of Disease regions by Socio-demographic Index (SDI), 1990–2016 The solid black line represents expected values based on SDI from a regression of all location data over the entire 1990 to 2016 estimation period.

References

    1. Stovner LJ, Hagen K, Jensen R. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193–210.
    1. WHO . World Health Organization; Geneva: 2001. The World Health Report 2001.
    1. Steiner TJ, Stovner LJ, Vos T. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain. 2016;17:104.
    1. Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia. 2005;25:12–15.
    1. Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia. 2011;31:1015–1022.
    1. Colas R, Munoz P, Temprano R, Gomez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology. 2004;62:1338–1342.
    1. Salomon JA, Vos T, Hogan DR. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012;380:2129–2143.
    1. Salomon JA, Haagsma JA, Davis A. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health. 2015;3:e712–e723.
    1. Classification Subcommittee of the International Headache Society The international classification of headache disorders, 2nd edn. Cephalalgia. 2004;24(suppl 1):1–160.
    1. Headache Classification Committee of the International Headache Society The International Classification of Headache Disorders, 3rd edn. Cephalalgia. 2018;38:1–211.
    1. Stovner LJ, Al Jumah M, Birbeck GL. The methodology of population surveys of headache prevalence, burden and cost: principles and recommendations from the Global Campaign against Headache. J Headache Pain. 2014;15:5.
    1. Truven Health Analytics; Ann Arbor: 2000. United States MarketScan Claims and Medicare Data.
    1. Truven Health Analytics; Ann Arbor: 2010. United States MarketScan Claims and Medicare Data.
    1. Truven Health Analytics; Ann Arbor: 2012. United States MarketScan Claims and Medicare Data.
    1. Ayzenberg I, Katsarava Z, Sborowski A. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia. 2012;32:373–381.
    1. Asberg AN, Stovner LJ, Zwart JA, Winsvold BS, Heuch I, Hagen K. Migraine as a predictor of mortality: The HUNT study. Cephalalgia. 2016;36:351–357.
    1. Wober-Bingol C. Epidemiology of migraine and headache in children and adolescents. Curr Pain Headache Rep. 2013;17:341.
    1. Hagen K, Zwart JA, Aamodt AH. A face-to-face interview of participants in HUNT 3: the impact of the screening question on headache prevalence. J Headache Pain. 2008;9:289–294.
    1. GBD 2016 Mortality Collaborators Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1084–1150.
    1. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–1259.
    1. WHO and Lifting The Burden . In: ATLAS of headache disorders and resources in the world 2011. Saxena S, Dua T, Saraceno B, editors. World Health Organization; Geneva: 2011.
    1. GBD 2016 DALYs and Hale Collaborators Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1260–1344.
    1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–1602.
    1. Diener HC, Holle D, Solbach K, Gaul C. Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol. 2016;12:575–583.
    1. Kim BK, Chung YK, Kim JM, Lee KS, Chu MK. Prevalence, clinical characteristics and disability of migraine and probable migraine: a nationwide population-based survey in Korea. Cephalalgia. 2013;33:1106–1116.
    1. Lanteri-Minet M, Valade D, Geraud G, Chautard MH, Lucas C. Migraine and probable migraine—results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification. Cephalalgia. 2005;25:1146–1158.
    1. Arruda MA, Guidetti V, Galli F, Albuquerque RC, Bigal ME. Primary headaches in childhood—a population-based study. Cephalalgia. 2010;30:1056–1064.
    1. Patel NV, Bigal ME, Kolodner KB, Leotta C, Lafata JE, Lipton RB. Prevalence and impact of migraine and probable migraine in a health plan. Neurology. 2004;63:1432–1438.
    1. Robberstad L, Dyb G, Hagen K, Stovner LJ, Holmen TL, Zwart JA. An unfavorable lifestyle and recurrent headaches among adolescents: the HUNT study. Neurology. 2010;75:712–717.
    1. Westergaard ML, Glumer C, Hansen EH, Jensen RH. Medication overuse, healthy lifestyle behaviour and stress in chronic headache: results from a population-based representative survey. Cephalalgia. 2016;36:15–28.
    1. Winsvold BS, Hagen K, Aamodt AH, Stovner LJ, Holmen J, Zwart JA. Headache, migraine and cardiovascular risk factors: the HUNT study. Eur J Neurol. 2011;18:504–511.
    1. Linde M, Edvinsson L, Manandhar K, Risal A, Steiner TJ. Migraine associated with altitude: results from a population-based study in Nepal. Eur J Neurol. 2017;24:1055–1061.
    1. GBD 2016 Risk Factors Collaborators Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study. Lancet. 2016;390:1345–1422.
    1. Hagen K, Vatten L, Stovner LJ, Zwart JA, Krokstad S, Bovim G. Low socio-economic status is associated with increased risk of frequent headache: a prospective study of 22718 adults in Norway. Cephalalgia. 2002;22:672–679.
    1. Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med. 2005;118(suppl 1):3S–10S.
    1. Gururaj G, Kulkarni GB, Rao GN, Subbakrishna DK, Stovner LJ, Steiner TJ. Prevalence and sociodemographic correlates of primary headache disorders: results of a population-based survey from Bangalore, India. Indian J Public Health. 2014;58:241–248.
    1. Giorgadze G, Mania M, Kukava M. Implementation of effective, self-sustaining headache services in the Republic of Georgia: evaluation of their impact on headache-related disability and quality of life of people with headache. Cephalalgia. 2018;38:639–645.
    1. Braschinsky M, Haldre S, Kals M. Structured education can improve primary-care management of headache: the first empirical evidence, from a controlled interventional study. J Headache Pain. 2016;17:24.
    1. Yu S, Steiner TJ. Lifting the burden of headache in China: managing migraine in a SMART way. J Headache Pain. 2017;18:79.
    1. Linde M, Steiner TJ, Chisholm D. Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries. J Headache Pain. 2015;16:496.
    1. Bendtsen L, Munksgaard S, Tassorelli C. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project) Cephalalgia. 2014;34:426–433.
    1. Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z. Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain. 2018;19:17.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다